Overview
See research options tied to sleep quality, stress resilience, anxiety, calmer evenings, and recovery-friendly downtime.
9 of 46 published compounds
$20.64
Sleep & Relaxation, Anxiety & Mood
deeper sleep, lower stress, calmer mood, better recovery nights
Goal hub next step
Build a sleep & stress research path.
Use the quiz before choosing a compound, vendor, or PDF so the route reflects your goal, risk tolerance, and monitoring comfort.
Best options to research first
Ranked by evidence first, then risk. A research starting point, not a clinical recommendation.
Oxytocin
Well-studied neuropeptide with extensive human research on social/emotional processing. Prescription product.
intranasal, intravenous
Acute effects studied within hours post-dose; mixed efficacy across conditions.
1 tracked
DSIP
Sleep-related peptide with human IV infusion studies showing sleep pressure effects. Mechanism uncertain.
intravenous, subcutaneous
Acute subjective effects reported after dosing; sleep architecture outcomes assessed same day/night.
€8.02
3 tracked
Selank
Tuftsin analogue peptide with anxiolytic/nootropic research and limited clinical GAD data.
intranasal
Some rapid responders described in clinical abstracts, but not broad RCT-grade evidence.
€20.64
3 tracked
Semax
ACTH fragment analogue with preclinical neurotrophic signaling and limited clinical stroke/cognition data.
intranasal
Gene expression changes within hours (animal); clinical stroke outcomes are longer-horizon.
€13.76
3 tracked
Hexarelin
GHRP-class secretagogue with stronger GH stimulation and studied sleep-endocrine effects.
subcutaneous, intravenous
Acute endocrine effects; sleep effects studied overnight.
0 tracked
Lower-risk options
NSI-189
Investigational neurogenic small molecule often discussed in nootropic circles despite limited human data.
Pinealon
Obscure pineal peptide marketed for anti-aging and sleep support with very weak published evidence.
Epithalon Variants
Modified epithalon-like peptides marketed for anti-aging despite essentially no variant-specific human evidence.
Trusted vendors for sleep and mood-oriented research
These vendors currently carry compounds in this goal category. Hub is the trust layer; outbound clicks happen after comparison.
XL Peptides
5 relevant compounds in hub
testing reports on product page
third-party testing reports linked on product page
UK, Europe, and rest of world via vendor shipping options
affiliate: direct product page
Amino Club
4 relevant compounds in hub
product page COA viewer
third-party purity testing; product-level COA on page
US/ROW (verify current policy)
affiliate: public program
Ignite Peptides
4 relevant compounds in hub
COA with order / verify current product report
third-party testing and COA documentation claimed by vendor; verify product-specific report
U.S. domestic territories only
affiliate: direct product page
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.